1. The relationship between NFKB, HER2, ER expression and anthracycline -based neoadjuvan chemotherapy response in local advanced stadium breast cancer: A cohort study in Eastern Indonesia
    null Indra et al, 2021, Annals of Medicine and Surgery CrossRef
  2. Monitoring total hemoglobin concentration changes across neoadjuvant chemotherapy in PgR-positive and PgR-negative breast cancer with diffuse optical tomography
    Mirella L. Altoe et al, 2019, Optical Tomography and Spectroscopy of Tissue XIII CrossRef
  3. Evaluation of hormone receptor, human epidermal growth factor receptor-2 and Ki-67 with core needle biopsy and neoadjuvant chemotherapy effects in breast cancer patients
    Wen-kai Ge et al, 2015, Thoracic Cancer CrossRef
  4. The role of quantitative estrogen receptor status in predicting tumor response at surgery in breast cancer patients treated with neoadjuvant chemotherapy
    Jacques Raphael et al, 2017, Breast Cancer Research and Treatment CrossRef
  5. The feasibility of 18F-FES and 18F-FDG microPET/CT for early monitoring the effect of fulvestrant on sensitizing docetaxel by downregulating ERα in ERα+ breast cancer
    Shuai Liu et al, 2018, Annals of Nuclear Medicine CrossRef
  6. Correlation between CA12 and TFF3 and their prediction value of neoadjuvant chemotherapy response in breast cancer
    Mengjia Shen et al, 2022, Journal of Clinical Pharmacy and Therapeutics CrossRef
  7. Development and Assessment of a Novel Core Biopsy-Based Prediction Model for Pathological Complete Response to Neoadjuvant Chemotherapy in Women with Breast Cancer
    Ailin Lan et al, 2023, International Journal of Environmental Research and Public Health CrossRef
  8. Estrogen Receptor α Roles in Breast Cancer Chemoresistance
    Chao-Yang Xu et al, 2013, Asian Pacific Journal of Cancer Prevention CrossRef